Inactive Instrument

Avivagen Inc Stock Toronto S.E.

VIV

CA05382F1036

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that enhances feed intake and supports immune function, thereby supporting general health and performance. The Companyâ€™s operations as one segment, products based on OxC-beta Technology. Its OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia.

Employees

Sector

Fishing & Farming

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	591K 509K 477K 436K 821K 56.48M 824K 5.66M 2.21M 28.51M 2.22M 2.17M 94.53M	P/E 2021	-3.05x	P/E 2022	-1.52x
Enterprise Value	6.39M 5.5M 5.16M 4.71M 8.87M 610M 8.9M 61.22M 23.88M 308M 23.98M 23.46M 1.02B	EV / Sales 2021	20.5x	EV / Sales 2022	17.7x
Free-Float	98.89%	Yield 2021 *	-	Yield 2022	-

24-04-24	Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	NE
21-04-06	Avivagen Discusses Significant Purchase Orders for OxC-beta(TM) Livestock with The Stock Day Podcast	NE
20-07-23	Avivagen: The OxC-beta(TM) Technology Is A True Game Changer	NE
19-10-02	Avivagen Inc. CEO, Kym Anthony, Joins The Stock Day Podcast to Discuss Their Expansion Strategy	NE
18-05-01	Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference	GL

Manager	Title	Age	Since
G. Anthony CEO	Chief Executive Officer	70	2017-02-08
Ira Levy DFI	Director of Finance/CFO	-	-
Drew Basek IRC	Investor Relations Contact	-	2017-02-28

Director	Title	Age	Since
David Hankinson CHM	Chairman	-	2005-08-03
G. Anthony CHM	Chairman	70	2014-07-24
Paul Mesburis BRD	Director/Board Member	56	2016-04-04

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVIVAGEN INC	-4.76%	-18.37%	-	-	77
GUANGDONG HAID GROUP CO., LIMITED	+1.85%	+0.98%	-24.81%	-1.20%	11.29B
NEW HOPE LIUHE CO.,LTD.	+1.41%	+3.91%	-27.43%	-38.82%	4.77B
PT CHAROEN POKPHAND INDONESIA TBK	+1.32%	+0.99%	-28.34%	-41.15%	2.83B
AKTIESELSKABET SCHOUW & CO.	+1.04%	+3.32%	+31.69%	+53.86%	2.7B
BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.	+1.80%	+6.60%	-19.86%	-48.48%	2.16B
FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED	+0.67%	+3.81%	-34.78%	-66.18%	1.22B
AVANTI FEEDS LIMITED	-0.05%	-3.33%	+30.42%	+90.15%	1.18B
GUANGDONG YUEHAI FEEDS GROUP CO.,LTD.	+2.25%	+4.46%	+6.09%	-6.93%	848M
WELLHOPE FOODS CO., LTD.	+1.08%	+4.31%	-24.68%	-26.79%	836M
Average	+0.66%	+3.28%	-10.19%	-9.51%	3.09B
Weighted average by Cap.	+1.50%	+2.19%	-16.90%	-9.95%

Avivagen Inc Stock Toronto S.E.

Stocks

VIV

CA05382F1036

Fishing & Farming

Valuation : Avivagen Inc

Press Releases : Avivagen Inc

Quotes and Performance

Managers and Directors : Avivagen Inc

Animal Feed

Financials

Company Profile

	2021	2022
Net sales	1.3M 1.12M 1.05M 956K 1.8M 124M 1.81M 12.42M 4.85M 62.53M 4.87M 4.76M 207M	939K 809K 759K 693K 1.3M 89.76M 1.31M 9M 3.51M 45.31M 3.53M 3.45M 150M
Net income	-6.39M -5.51M -5.17M -4.72M -8.88M -611M -8.91M -61.29M -23.91M -308M -24.01M -23.48M -1.02B	-6.07M -5.23M -4.9M -4.47M -8.43M -580M -8.46M -58.15M -22.69M -293M -22.78M -22.28M -970M
Net Debt	5.4M 4.65M 4.36M 3.98M 7.5M 516M 7.52M 51.75M 20.19M 260M 20.27M 19.83M 864M	5.8M 4.99M 4.68M 4.27M 8.05M 554M 8.08M 55.55M 21.67M 280M 21.76M 21.29M 927M